|
GB922029A
(en)
|
1960-05-19 |
1963-03-27 |
Equilibre Biolog L |
Therapeutic composition
|
|
US3051619A
(en)
|
1960-05-19 |
1962-08-28 |
Equilibre Biolog L |
4-hydroxy butyric acid therapeutic compositions and process of use for clinical sedation, hypnosis, or anaesthesia
|
|
DE1642902A1
(de)
|
1965-09-30 |
1971-05-19 |
Unilever Nv |
Verfahren zur kontinuierlichen Entsaeuerung von Glyceridoelen
|
|
US4221778A
(en)
|
1979-01-08 |
1980-09-09 |
Pennwalt Corporation |
Prolonged release pharmaceutical preparations
|
|
US4374441A
(en)
|
1980-05-23 |
1983-02-22 |
Book Covers, Inc. |
Method of making a book cover and pocket element therefor
|
|
ZA814854B
(en)
|
1980-07-17 |
1982-07-28 |
J Klosa |
Nonhygroscopic salts of 4-hydroxybutryric acid, methods of their production and pharmaceutical preparations containing these salts
|
|
EP0044801B1
(de)
|
1980-07-17 |
1984-02-15 |
Josef Dr. Klosa |
Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel
|
|
CH655507B
(https=)
|
1983-01-12 |
1986-04-30 |
|
|
|
US4524217A
(en)
|
1984-06-08 |
1985-06-18 |
Celanese Corporation |
Process for producing N-acyl-hydroxy aromatic amines
|
|
EP0235408B1
(en)
|
1984-08-06 |
1991-01-09 |
The University Of Toronto Innovations Foundation |
Pharmaceutical composition and treatment
|
|
US4687662A
(en)
|
1985-08-30 |
1987-08-18 |
Warner-Lambert Company |
Therapeutic effervescent composition
|
|
IE59106B1
(en)
|
1985-05-31 |
1994-01-12 |
Warner Lambert Co |
A therapeutic effervescent composition and a method of preparing the same
|
|
US4738985A
(en)
|
1986-03-19 |
1988-04-19 |
The University Of Toronto Innovations Foundations |
Pharmaceutical composition and treatment
|
|
DE3804168A1
(de)
|
1988-02-11 |
1989-08-24 |
Gewerk Eisenhuette Westfalia |
Planetenueberlagerungsgetriebe und ueberlagerungsantrieb fuer kettenbaender u. dgl., insbesondere fuer kettenfoerderer und kettengezogene bergbau-gewinnungsmaschinen
|
|
IT1217783B
(it)
|
1988-06-03 |
1990-03-30 |
Farmaceutico Ct S R L Lab |
Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
|
|
US5294430A
(en)
|
1988-09-12 |
1994-03-15 |
University Of Rochester |
Use of dithiocarbamates to treat myelosuppression
|
|
US4916161A
(en)
|
1988-10-25 |
1990-04-10 |
Bristol-Myers Squibb |
Taste-masking pharmaceutical agents
|
|
JP2564690B2
(ja)
|
1990-06-14 |
1996-12-18 |
三省製薬 株式会社 |
メラニン生成抑制外用剤
|
|
DE4113984C2
(de)
|
1991-04-29 |
2002-05-08 |
Koehler Chemie Dr Franz |
Salze der 4-Hydroxy-Buttersäure
|
|
ES2053411T3
(es)
|
1991-07-01 |
1995-05-01 |
Gerhard Gergely |
Sistemas efervescentes dotados de reaccion.
|
|
IT1271403B
(it)
|
1993-03-26 |
1997-05-28 |
Ct Lab Farm Srl |
Sali dell'acido gamma-idrossibutirrico ad attivita' ansiolitica e per il trattamento degli stati depressivi
|
|
DK0707475T3
(da)
|
1993-06-14 |
1997-12-29 |
Janssen Pharmaceutica Nv |
Langsom frigørende, filmcoatet tablet af astemizol og pseudoephedrin
|
|
IT1266565B1
(it)
*
|
1993-07-22 |
1997-01-09 |
Ct Lab Farm Srl |
Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
|
|
US5833599A
(en)
|
1993-12-13 |
1998-11-10 |
Multum Information Services |
Providing patient-specific drug information
|
|
DE4432757A1
(de)
*
|
1994-09-14 |
1996-03-21 |
Boehringer Mannheim Gmbh |
Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
|
|
FR2725623A1
(fr)
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
|
|
US7072840B1
(en)
|
1994-10-28 |
2006-07-04 |
Cybear, L.L.C. |
Prescription management system
|
|
US5845255A
(en)
|
1994-10-28 |
1998-12-01 |
Advanced Health Med-E-Systems Corporation |
Prescription management system
|
|
GB9423542D0
(en)
|
1994-11-22 |
1995-01-11 |
Marples Brian A |
Pharmaceutical compounds
|
|
JP4072597B2
(ja)
*
|
1994-12-27 |
2008-04-09 |
ナムローゼ・フェンノートシャップ・オルガノン |
持続性製剤
|
|
US5758095A
(en)
|
1995-02-24 |
1998-05-26 |
Albaum; David |
Interactive medication ordering system
|
|
US5840331A
(en)
|
1995-06-07 |
1998-11-24 |
Arch Development Corporation |
Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin
|
|
US6112182A
(en)
|
1996-01-16 |
2000-08-29 |
Healthcare Computer Corporation |
Method and apparatus for integrated management of pharmaceutical and healthcare services
|
|
IT1283782B1
(it)
|
1996-08-09 |
1998-04-30 |
Ct Lab Farm Srl |
Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo
|
|
US20080292700A1
(en)
*
|
1997-04-21 |
2008-11-27 |
Biovail Laboratories |
Controlled release formulations using intelligent polymers
|
|
US5990162A
(en)
*
|
1997-08-29 |
1999-11-23 |
Orphan Medical, Inc. |
Method for treatment of fibromyalgia and chronic fatigue syndrome
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6472432B1
(en)
|
1997-11-17 |
2002-10-29 |
Nicholas V. Perricone |
Treatment of rosacea using lipoic acid
|
|
US6014631A
(en)
|
1998-04-02 |
2000-01-11 |
Merck-Medco Managed Care, Llc |
Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry
|
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
|
EP1316309A1
(en)
|
1998-12-23 |
2003-06-04 |
Orphan Medical Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
DK1140061T3
(da)
|
1998-12-23 |
2003-08-25 |
Orphan Medical Inc |
Mikrobiologisk sunde og stabile opløsninger af gamma-hydroxybutyratsalt til behandling af narcolepsi
|
|
US6067524A
(en)
|
1999-01-07 |
2000-05-23 |
Catalina Marketing International, Inc. |
Method and system for automatically generating advisory information for pharmacy patients along with normally transmitted data
|
|
US6565872B2
(en)
|
1999-02-16 |
2003-05-20 |
Xiao Yu Wu |
Polymeric system for drug delivery and solute separation
|
|
US6384020B1
(en)
|
1999-07-14 |
2002-05-07 |
Shire Laboratories, Inc. |
Rapid immediate release oral dosage form
|
|
ES2383673T3
(es)
|
2000-09-22 |
2012-06-25 |
Jpi Commercial, Llc |
Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos
|
|
WO2002045684A2
(en)
|
2000-12-06 |
2002-06-13 |
Pharmacia Corporation |
Rapidly dispersing pharmaceutical composition comprising effervescent agents
|
|
FR2830447B1
(fr)
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
US20030180249A1
(en)
|
2002-03-18 |
2003-09-25 |
Khanna Satish Chandra |
Dosage forms for hygroscopic active ingredients
|
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
RU2210360C1
(ru)
|
2002-09-19 |
2003-08-20 |
Общество С Ограниченной Ответственностью "Консорциум-Пик" |
Психотропное средство
|
|
US7668730B2
(en)
|
2002-12-17 |
2010-02-23 |
JPI Commercial, LLC. |
Sensitive drug distribution system and method
|
|
ATE482699T1
(de)
|
2002-12-23 |
2010-10-15 |
Merck Frosst Company |
Pharmazeutische zusammensetzungen und verfahren zur behandlung von morbus parkinson
|
|
US20050031688A1
(en)
|
2003-08-04 |
2005-02-10 |
Ayala William J. |
Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
|
|
ME00391B
(me)
|
2003-08-08 |
2011-10-10 |
Biovail Laboratories Int Srl |
Tableta bupropion hidrohlorida sa modifikovanim otpuštanjem
|
|
JP2007501810A
(ja)
|
2003-08-11 |
2007-02-01 |
メルク フロスト カナダ リミテツド |
一段階被覆法を用いて作製された着香味遮蔽製薬製剤
|
|
US20050142192A1
(en)
|
2003-10-15 |
2005-06-30 |
Wyeth |
Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
|
|
KR20070100686A
(ko)
|
2004-09-07 |
2007-10-11 |
오르펀 메디칼, 인크. |
개선된 ｇｈｂ 조성물
|
|
US8193211B2
(en)
*
|
2004-09-30 |
2012-06-05 |
Supernus Pharmaceuticals, Inc. |
Controlled release compositions of gamma-hydroxybutyrate
|
|
AR051397A1
(es)
|
2004-10-21 |
2007-01-10 |
Novartis Ag |
Composicion farmaceutica
|
|
MX2007005679A
(es)
|
2004-11-10 |
2007-07-11 |
Univ Columbia |
Metodo para tratamiento de desordenes de movimiento.
|
|
EA014249B1
(ru)
*
|
2005-01-27 |
2010-10-29 |
Алембик Лимитед |
Формуляция леветирацетама длительного высвобождения
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
WO2006124609A2
(en)
|
2005-05-16 |
2006-11-23 |
Joseph Johnson |
Methods and compositions for treating arg
|
|
US7645802B2
(en)
*
|
2005-06-27 |
2010-01-12 |
Biovail Laboratories International Srl. |
Bupropion hydrobromide and therapeutic applications
|
|
WO2007016563A2
(en)
|
2005-08-01 |
2007-02-08 |
Alpharma Inc. |
Alcohol resistant pharmaceutical formulations
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20070264346A1
(en)
|
2006-02-16 |
2007-11-15 |
Flamel Technologies |
Multimicroparticulate pharmaceutical forms for oral administration
|
|
US8309104B2
(en)
*
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
|
CN102488652B
(zh)
|
2006-03-16 |
2014-06-18 |
特瑞斯制药股份有限公司 |
含有药物-离子交换树脂复合物的经修饰释放的制剂
|
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
|
US20080069871A1
(en)
*
|
2006-07-21 |
2008-03-20 |
Vaughn Jason M |
Hydrophobic abuse deterrent delivery system
|
|
US20080085304A1
(en)
|
2006-10-10 |
2008-04-10 |
Penwest Pharmaceuticals Co. |
Robust sustained release formulations
|
|
US8394845B2
(en)
|
2006-10-30 |
2013-03-12 |
Hanall Biopharma Co., Ltd. |
Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
|
|
JP2010510320A
(ja)
|
2006-11-21 |
2010-04-02 |
マクニール−ピーピーシー・インコーポレーテツド |
改変型放出鎮痛性懸濁液
|
|
EP2104493A2
(en)
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
US7568822B2
(en)
|
2007-03-28 |
2009-08-04 |
Visteon Global Technologies, Inc. |
Predictive adaptive front lighting algorithm for branching road geometry
|
|
US8202542B1
(en)
|
2007-05-31 |
2012-06-19 |
Tris Pharma |
Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
|
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
|
US8778398B2
(en)
|
2008-11-04 |
2014-07-15 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
|
US8771735B2
(en)
*
|
2008-11-04 |
2014-07-08 |
Jazz Pharmaceuticals, Inc. |
Immediate release dosage forms of sodium oxybate
|
|
FR2938431B1
(fr)
|
2008-11-14 |
2013-12-20 |
Debregeas Et Associes Pharma |
Nouvelle composition a base d'acide gamma-hydroxybutyrique
|
|
CA2759251C
(en)
|
2009-04-23 |
2017-01-03 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
FR2951378B1
(fr)
|
2009-10-16 |
2012-06-01 |
Flamel Tech Sa |
Forme pharmaceutique orale solide anti-mesusage et dotee d'un profil specifique de liberation modifiee
|
|
MX391660B
(es)
|
2010-03-24 |
2025-03-21 |
Jazz Pharmaceuticals Inc |
Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas
|
|
EP2555749B1
(en)
|
2010-04-06 |
2016-10-26 |
Allergan, Inc. |
Sustained-release reservoir implants for intracameral drug delivery
|
|
WO2011127252A2
(en)
|
2010-04-07 |
2011-10-13 |
Proteus Biomedical, Inc. |
Miniature ingestible device
|
|
EP2386289A1
(en)
|
2010-04-29 |
2011-11-16 |
Ipsen Pharma S.A.S. |
Clay compositions
|
|
CN102946869B
(zh)
|
2010-05-04 |
2016-08-03 |
爵士制药有限公司 |
γ-羟基丁酸的速释制剂及剂型
|
|
EP2566488B1
(en)
|
2010-05-07 |
2016-07-13 |
Microdermis Corporation |
Povidone-iodine topical composition
|
|
JP5826261B2
(ja)
|
2010-06-28 |
2015-12-02 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
癌に対する使用のためのキナーゼ阻害剤としての２，４−ジアリール置換［１，８］ナフチリジン
|
|
GB201014633D0
(en)
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
US8617602B2
(en)
|
2010-09-03 |
2013-12-31 |
William Wayne Howard |
Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
|
|
TWI507397B
(zh)
|
2010-09-30 |
2015-11-11 |
Toyama Chemical Co Ltd |
６－氟－３－羥－２－吡羧醯胺之美洛明鹽
|
|
SG189161A1
(en)
|
2010-09-30 |
2013-05-31 |
Toyama Chemical Co Ltd |
Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
|
|
US8623409B1
(en)
|
2010-10-20 |
2014-01-07 |
Tris Pharma Inc. |
Clonidine formulation
|
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
|
BR112013019431A2
(pt)
|
2011-02-02 |
2020-10-27 |
Alpharma Pharmaceuticals, Llc |
composição farmacêutica compreendendo agonista opioide e antagonista sequestrado
|
|
FR2971422B1
(fr)
|
2011-02-11 |
2016-05-20 |
Debregeas Et Associes Pharma |
Granules d'acide gamma-hydroxybutyrique
|
|
ES2804540T3
(es)
|
2011-02-14 |
2021-02-08 |
Concert Pharmaceuticals Inc |
Análogos deuterados de ácido 4hidroxibutírico
|
|
KR20140045931A
(ko)
|
2011-04-15 |
2014-04-17 |
쓰레솔드 파마슈티컬스, 인코포레이티드 |
경구 투여를 위한 단위투여량 형태
|
|
US8680228B2
(en)
|
2011-09-27 |
2014-03-25 |
Tepha, Inc. |
Controlled hydrolysis of poly-4-hydroxybutyrate and copolymers
|
|
US20160068463A1
(en)
|
2012-11-14 |
2016-03-10 |
Metabolix, Inc. |
Production of salts of 4-hydroxybutyrate using biobased raw materials
|
|
FR2999426B1
(fr)
|
2012-12-13 |
2015-01-02 |
Flamel Tech Sa |
Forme orale multiparticulaire a liberation immediate d'au moins un compose actif, comprenant des particules enrobees resistantes au broyage.
|
|
US8591922B1
(en)
|
2012-12-14 |
2013-11-26 |
Jazz Pharmacuticals, Inc. |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US9050302B2
(en)
|
2013-03-01 |
2015-06-09 |
Jazz Pharmaceuticals Ireland Limited |
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
US20150005334A1
(en)
|
2013-03-15 |
2015-01-01 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
|
US9801852B2
(en)
|
2013-08-30 |
2017-10-31 |
Jazz Pharmaceuticals, Inc. |
Devices and methods for facilitating and controlling use of a medication
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
WO2017147375A1
(en)
|
2016-02-24 |
2017-08-31 |
Chemapotheca, Llc |
Amphetamine controlled release, prodrug, and abuse deterrent dosage forms
|
|
MY177906A
(en)
|
2014-02-06 |
2020-09-25 |
Sequential Medicine Ltd |
Composition and method for aiding sleep
|
|
US10166183B2
(en)
|
2014-02-07 |
2019-01-01 |
Auspex Pharmaceuticals, Inc. |
Pharmaceutical formulations
|
|
EP3137060B2
(en)
|
2014-05-01 |
2023-12-20 |
Sun Pharmaceutical Industries Ltd |
Extended release suspension compositions
|
|
US9962336B2
(en)
|
2014-05-01 |
2018-05-08 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
|
US20160317388A1
(en)
|
2014-05-01 |
2016-11-03 |
Sun Pharmaceutical Industries Limited |
Dual-chamber pack for extended release suspension compositions
|
|
MA41124A
(fr)
|
2014-12-05 |
2017-10-10 |
Sun Pharmaceutical Ind Ltd |
Compositions en suspension à libération prolongée à rétention gastrique
|
|
US10398662B1
(en)
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
|
CA2984725A1
(en)
|
2015-05-01 |
2016-11-10 |
Sun Pharmaceutical Industries Limited |
Dual-chamber pack for extended release suspension compositions
|
|
US11000498B2
(en)
|
2016-07-22 |
2021-05-11 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
UY37341A
(es)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
|
|
US20180263936A1
(en)
|
2017-03-17 |
2018-09-20 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
JP7349428B2
(ja)
|
2017-12-20 |
2023-09-22 |
フラメル アイルランド リミテッド |
改善された安定性を有するパッケージされた修飾放出ガンマ－ヒドロキシブチラート製剤
|
|
BR112021006027A2
(pt)
|
2018-11-19 |
2021-06-29 |
Jazz Pharmaceuticals Ireland Limited |
formulações de fármaco resistente a álcool
|
|
CN113473980A
(zh)
|
2019-03-01 |
2021-10-01 |
弗拉梅尔爱尔兰有限公司 |
在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
|
|
US20210186907A1
(en)
|
2019-12-24 |
2021-06-24 |
Jazz Pharmaceuticals Ireland Limited |
Ghb dosing
|